|
|
||||||||
Technical Briefs |
Departments of
1
Child Health,
2 Pathology and Anatomical Sciences, and
3
Internal Medicine, University of Missouri School of Medicine, 1 Hospital Dr., Columbia, MO 65212
4 Kidney & Hypertension Center, 1210 Hicks Blvd., Fairfield, OH 45014
5 Renal Physicians, Inc., 4700 Springboro Pike, Dayton, OH 45439
6 Department of Statistics/Biostatistics, 223 Math Sciences Bldg., University of Missouri, Columbia, MO 65211
aaddress correspondence to this author at: Department of Child Health, M767, University of Missouri School of Medicine, 1 Hospital Dr., Columbia, MO 65212; fax 573-884-8823, e-mail LittleR@health.missouri.edu
Many factors can affect interpretation of glycohemoglobin (GHB/HbA1c) measurements in patients with chronic renal failure (CRF). Several reports have suggested that erythrocyte survival is substantially lowered in most patients with CRF; this would be expected to lower GHB results (1)(2)(3)(4)(5)(6). Several reports have also suggested that GHB methods, especially those based on charge separation (e.g., ion-exchange HPLC), may have interference by carbamylated hemoglobin that would be expected to falsely increase GHB results (7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17). Many of these reports evaluated older assay methods; newer ion-exchange methods may show improved separation of the HbA1c fraction from other hemoglobin adducts (15)(17).
Because renal failure is common in patients with diabetes and GHB is widely used as an index of mean blood glucose in these patients, we examined GHB results in patients with CRF by several different GHB assay methods. We also investigated the impact of shortened erythrocyte lifespan by comparing the GHB results obtained for nondiabetic patients with and without CRF.
Fifty-five patients with CRF (blood urea nitrogen >400 mg/L) were recruited for this study. Twenty-nine were
Acknowledgments
References
The following articles in journals at HighWire Press have cited this article:
![]() |
E S Kilpatrick Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus J. Clin. Pathol., September 1, 2008; 61(9): 977 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Tascona, A. R. Morton, E. B. Toffelmire, D. C. Holland, and E. A. Iliescu Adequacy of Glycemic Control in Hemodialysis Patients With Diabetes Diabetes Care, October 1, 2006; 29(10): 2247 - 2251. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rigalleau, C. Lasseur, C. Raffaitin, C. Perlemoine, N. Barthe, P. Chauveau, C. Combe, and H. Gin Glucose Control Influences Glomerular Filtration Rate and Its Prediction in Diabetic Subjects Diabetes Care, July 1, 2006; 29(7): 1491 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hoelzel, C. Weykamp, J.-O. Jeppsson, K. Miedema, J. R. Barr, I. Goodall, T. Hoshino, W. G. John, U. Kobold, R. Little, et al. IFCC Reference System for Measurement of Hemoglobin A1c in Human Blood and the National Standardization Schemes in the United States, Japan, and Sweden: A Method-Comparison Study Clin. Chem., January 1, 2004; 50(1): 166 - 174. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |